Market Research Logo

Head And Neck Cancer - Pipeline Review, H2 2018

Head And Neck Cancer - Pipeline Review, H2 2018

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Head And Neck Cancer - Pipeline Review, H2 2018, provides an overview of the Head And Neck Cancer (Oncology) pipeline landscape.

Head and Neck Cancer is a cancer that arises in the head or neck region (in the nasal cavity, sinuses, lips, mouth, salivary glands, throat, or larynx). The common symptoms of cancer of the head and neck include persistent pain in the throat, pain or difficulty with swallowing, persistent hoarseness or a change in voice, pain in the ear and bleeding in the mouth or throat. The disease may be controlled by chemotherapy and radiation therapy.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Head And Neck Cancer - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Head And Neck Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Head And Neck Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Head And Neck Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 1, 17, 134, 143, 5, 89, 23 and 7 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Phase 0, Preclinical, Discovery and Unknown stages comprises 9, 8, 1, 19, 4 and 1 molecules, respectively.

Head And Neck Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

  • The pipeline guide provides a snapshot of the global therapeutic landscape of Head And Neck Cancer (Oncology).
  • The pipeline guide reviews pipeline therapeutics for Head And Neck Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Head And Neck Cancer (Oncology) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Head And Neck Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Head And Neck Cancer (Oncology)
Reasons to buy
  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Head And Neck Cancer (Oncology).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Head And Neck Cancer (Oncology) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.


Introduction
Head And Neck Cancer - Overview
Head And Neck Cancer - Therapeutics Development
Head And Neck Cancer - Therapeutics Assessment
Head And Neck Cancer - Companies Involved in Therapeutics Development
Head And Neck Cancer - Drug Profiles
Head And Neck Cancer - Dormant Projects
Head And Neck Cancer - Discontinued Products
Head And Neck Cancer - Product Development Milestones
Appendix
List of Tables
Number of Products under Development for Head And Neck Cancer, H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products under Development by Universities/Institutes, H2 2018
Products under Development by Companies, H2 2018
Products under Development by Universities/Institutes, H2 2018
Number of Products by Stage and Target, H2 2018
Number of Products by Stage and Mechanism of Action, H2 2018
Number of Products by Stage and Route of Administration, H2 2018
Number of Products by Stage and Molecule Type, H2 2018
Head And Neck Cancer - Pipeline by 4SC AG, H2 2018
Head And Neck Cancer - Pipeline by AbbVie Inc, H2 2018
Head And Neck Cancer - Pipeline by Abion Inc, H2 2018
Head And Neck Cancer - Pipeline by Adaptimmune Therapeutics Plc, H2 2018
Head And Neck Cancer - Pipeline by ADC Therapeutics SA, H2 2018
Head And Neck Cancer - Pipeline by Admedus Ltd, H2 2018
Head And Neck Cancer - Pipeline by Aduro BioTech Inc, H2 2018
Head And Neck Cancer - Pipeline by Advaxis Inc, H2 2018
Head And Neck Cancer - Pipeline by Advenchen Laboratories LLC, H2 2018
Head And Neck Cancer - Pipeline by Affimed GmbH, H2 2018
Head And Neck Cancer - Pipeline by Alkermes Plc, H2 2018
Head And Neck Cancer - Pipeline by Altor BioScience Corp, H2 2018
Head And Neck Cancer - Pipeline by Ambrx Inc, H2 2018
Head And Neck Cancer - Pipeline by amcure GmbH, H2 2018
Head And Neck Cancer - Pipeline by Amgen Inc, H2 2018
Head And Neck Cancer - Pipeline by AMI Onco Theranostics LLC, H2 2018
Head And Neck Cancer - Pipeline by Apexigen Inc, H2 2018
Head And Neck Cancer - Pipeline by Arcus Biosciences Inc, H2 2018
Head And Neck Cancer - Pipeline by Argenx SE, H2 2018
Head And Neck Cancer - Pipeline by ArQule Inc, H2 2018
Head And Neck Cancer - Pipeline by Array BioPharma Inc, H2 2018
Head And Neck Cancer - Pipeline by Ascentage Pharma Group Corp Ltd, H2 2018
Head And Neck Cancer - Pipeline by Astellas Pharma Inc, H2 2018
Head And Neck Cancer - Pipeline by Astex Pharmaceuticals Inc, H2 2018
Head And Neck Cancer - Pipeline by AstraZeneca Plc, H2 2018
Head And Neck Cancer - Pipeline by Atara Biotherapeutics Inc, H2 2018
Head And Neck Cancer - Pipeline by Aurigene Discovery Technologies Ltd, H2 2018
Head And Neck Cancer - Pipeline by AVEO Pharmaceuticals Inc, H2 2018
Head And Neck Cancer - Pipeline by Bayer AG, H2 2018
Head And Neck Cancer - Pipeline by BeiGene Ltd, H2 2018
Head And Neck Cancer - Pipeline by Benitec Biopharma Ltd, H2 2018
Head And Neck Cancer - Pipeline by Bexion Pharmaceuticals LLC, H2 2018
Head And Neck Cancer - Pipeline by Biohaven Pharmaceutical Holding Company Ltd, H2 2018
Head And Neck Cancer - Pipeline by BioLineRx Ltd, H2 2018
Head And Neck Cancer - Pipeline by Biomics Biotechnologies Co Ltd, H2 2018
Head And Neck Cancer - Pipeline by Bionovis SA, H2 2018
Head And Neck Cancer - Pipeline by BioNTech AG, H2 2018
Head And Neck Cancer - Pipeline by Biothera Pharmaceutical Inc, H2 2018
Head And Neck Cancer - Pipeline by Boehringer Ingelheim GmbH, H2 2018
Head And Neck Cancer - Pipeline by Boston Biomedical Inc, H2 2018
List of Figures
Number of Products under Development for Head And Neck Cancer, H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products under Development by Universities/Institutes, H2 2018
Number of Products by Top 10 Targets, H2 2018
Number of Products by Stage and Top 10 Targets, H2 2018
Number of Products by Top 10 Mechanism of Actions, H2 2018
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2018
Number of Products by Top 10 Routes of Administration, H2 2018
Number of Products by Stage and Top 10 Routes of Administration, H2 2018
Number of Products by Top 10 Molecule Types, H2 2018
Number of Products by Stage and Top 10 Molecule Types, H2 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report